Stimcell Energetics Inc. financials

STME CIK 0001493712

Source: EDGAR filings · Built 2026-06-19T03:11:10Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -450.59K -562.01K -928.31K
Net Debt -43.41K 67.31K 86.51K 85.08K 457.35K
Gross Margin 17.49% 89.32%
Net Margin -17923.32% -1140.32%
Return on Equity (ROE) 45.44% 17.24% 20.75% 34.71% 57.79% 71.87%
Return on Assets (ROA) -2668.42% -308.93% -479.37% -1686.77% -1743.49% -686.46%
Debt-to-Equity 0.00× -0.07× -0.06× -0.07× -0.33×
Cash Conversion Ratio 0.25× 1.02× 0.55× 0.65× 0.62× 0.85×
Accruals Ratio -20.01× 0.07× -2.16× -5.97× -6.71× -1.05×
CapEx Coverage -356.06× -375.90×
Free Cash Flow Per Share $-0.01 $-0.01 $-0.02

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 0 2.76K 95.82K
Cost of Goods and Services Sold 2.03K 3.24K 10.24K
Gross Profit 0 483 4.03K 3.52K 85.59K
Research and Development Expense 89.22K 150.71K 229.58K 393.22K
Operating Expenses 522.11K 268.35K 448.14K 675.73K 728.68K 1.12M
Net Income (Loss) Attributable to Parent -697.38K -910.84K -1.09M
Earnings Per Share, Basic $-0.03 $-0.01 $-0.01 $-0.01 $-0.02
Weighted Average Number of Shares Outstanding, Basic 19.84M 10.73M 62.92M 62.80M 58.76M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 20.75K 45.09K
Assets, Current 41.34K 51.05K 157.34K
Assets 21.22K 46.12K 103.27K 41.34K 52.24K 159.18K
Liabilities 1.27M 872.58K 2.49M 2.05M 1.63M 1.68M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -141.60K -145.90K -272.21K -450.59K -560.43K
Payments to Acquire Property, Plant, and Equipment 0 1.57K 2.46K
Net Cash Provided by (Used in) Investing Activities 0 -1.57K -2.46K
Net Cash Provided by (Used in) Financing Activities 112.86K 91.03K 346.36K 453.97K 535.10K 916.42K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (STME CIK 0001493712), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

KDKRW

KODIAK AI, INC.

SNOA

SONOMA PHARMACEUTICALS, INC.

BWA

BORGWARNER INC